Novartis AG
NVSNYSEPharmaceutical PreparationsFiscal year ends December 31Also trades as NVSEF
$160.79−0.31 (-0.19%)
Close on Oct 30, 2026Market cap $306.81BP/E 22.5Yield –
Novartis Total Headcount — ex-Sandoz by Year
Novartis Total Headcount — ex-Sandoz: 77,052 in FY2025, down 1.6% from a year earlier.
Latest, FY2025
77,052
Period ended Dec 31, 2025
Change on a year earlier
-1.6%
78,310 in FY2024
History
3 years
Since FY2023
Sources
2
Documents cited below
Where the FY2025 figure comes from
“| Headcount | 77 052 | 78 310 | ∆ |”
Source: Novartis Official IR / Sustainability Report — novartis-esg-data-summary-2025.pdf ↗
Reported in ESG Data Summary 2025 & Nonfinancial Report.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Total Headcount — ex-Sandoz | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 77,052 | -1.6% | Novartis Official IR / Sustainability Report — novartis-esg-data-summary-2025.pdf ↗ |
| FY2024 | Dec 31, 2024 | 78,310 | -0.1% | Novartis Official IR / Sustainability Report — novartis-esg-data-summary-2025.pdf ↗ |
| FY2023 | Dec 31, 2023 | 78,407 | – | Novartis Form 6-K (0001370368-25-000008) ↗ |
Cite this data
StockData. (2026). Novartis Total Headcount — ex-Sandoz, annual FY2023–FY2025 [Data set]. Compiled from Novartis SEC filings and investor materials. https://stockdatahq.com/stocks/nvs/kpis/wf-headcount-total
See every metric in the Novartis KPI table. Data updated Nov 2, 2026.